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Results Sensitivity, specificity, PPV and NPV of aABI for 
detecting PAD was 73%, 100%, 100%, and 86% as com-
pared to 80%, 96%, 92%, and 89% for sABI. Pearson-corre-
lation for diabetics was r = 0.81; (P < .001) and for non-dia-
betics r = 0.77; (P < .001). Bland–Altman-analysis revealed 
a difference (95% CI) for diabetics of 0.09 (−0.22–0.4] 
and non-diabetics 0.022 [−0.25–0.295]. Weak correlation 
exists for FMD/AS analysis (pre-interventional R = 0.386, 
P = .043; post-interventional R = −0.06; P = .76) and sig-
nificant increase of pre-/post-interventional PWV analysis 
(P < .001).
Conclusion Combined automatic ABI and PWV acquisi-
tion with the VascAssist device showed excellent diagnos-
tic accuracy for detection of PAD. Compared to FMD, AS 
analysis may serve as an investigator-independent (screen-
ing) tool for determination of functional vascular damage 
in atherosclerosis.
Keywords Atherosclerosis · Ankle-brachial index · 
Arterial stiffness · Vascular resistance · Flow-mediated 
dilation
Introduction
Atherosclerosis is the major reason for cardiovascular-
related death in western countries. The disease is mostly 
asymptomatic at an early stage. Screening for peripheral 
artery disease (PAD) is usually made by non-invasive 
measurement of ankle-brachial index (ABI) [1–3]. In con-
trast to usual manual ABI assessment, automated assess-
ment is more efficient [4] and less time-consuming without 
the need for specific training [5, 6]. Unfortunately, statisti-
cal evaluation of validity and reliability between automated 
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Objective Evaluation of diagnostic accuracy of an oscil-
lometry-based device (VascAssist) combining fully auto-
mated ankle-brachial index (ABI) and pulse-wave velocity 
(PWV) assessment for detection of peripheral arterial dis-
ease (PAD).
Subjects and methods 110 consecutive subjects including 
symptomatic PAD patients (n = 41) and healthy PAD-free 
participants (n = 69) were recruited. All subjects underwent 
standard manual Doppler-based ABI (sABI) and oscillom-
etry-based automated ABI (aABI) measurements (VascAs-
sist). Oscillometry by the VascAssist included central and 
peripheral PWV assessment. Additionally, arterial stiffness 
(AS) was evaluated by flow-mediated vasodilation (FMD) 
of the brachial artery in all patients. All symptomatic PAD 
patients underwent catheter angiography for endovascular 
intervention and post-interventional acquisition of sABI, 
aABI, PWV and FMD.
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and standard ABI assessment in previous studies was often 
imprecise [7].
Early detection of initial vascular damage is achievable 
by assessment of endothelial function [8]. In addition to 
ABI, non-invasive flow-mediated dilatation (FMD) is an 
early marker for atherosclerosis, and has been identified as 
a predictor for potential cardiovascular events [9]. Despite 
a high level of standardization, the time-consuming meas-
uring of FMD highly depends on an operator’s expertise, 
necessitates patient’s compliance and is altered by a num-
ber of environmental variables [10].
Moreover, arterial stiffness is evaluable by pulse-wave 
analysis (PWA) of aortic/brachial pulse-wave velocity 
(PWV). Increased aortic PWV, augmentation index (AUI), 
and decreased arterial elasticity are typically present in 
patients with PAD [11, 12]. These findings are clearly iden-
tified as independent predictors for cardiovascular-disease-
related morbidity and mortality [13–15]. Decreased small 
artery elasticity and increased AUI are associated with 
pathologic ABI [16, 17], which is the most important pre-
dictor for PAD and cardiovascular risk [18].
The beforehand mentioned diagnostic tests use different 
approaches to assess arterial distensibility as a surrogate for 
vascular function. Reduced distensibility, or arterial stiff-
ness (AS) can essentially be expressed by the relationship 
between aortic compliance and total peripheral arterial 
resistance, which are derived from PWV analysis of oscil-
lometrically acquired blood pressure curves [19].
The purpose of our study was to validate the diagnos-
tic accuracy of a dedicated oscillometric automated device 
(VascAssist) in patients with known PAD and healthy vol-
unteers. The primary objective was to compare manual 
ankle-brachial index (sABI) measurement using Doppler-
ultrasound and mercury-sphygmomanometry as the refer-
ence standard vs. investigator-independent automated ABI 
(aABI) measurement. Secondary objectives included AS 
compared to (pre- and post-interventional) sABI, aABI and 
FMD.
Materials and methods
Overall, 110 subjects were consecutively recruited includ-
ing 41 patients [female 15%, mean age 69.0 ± standard 
deviation 11.4 (range 40–94) years, n = 20 diabetics] with 
symptomatic PAD and impaired walking capacity <200 m 
(intervention-group), and 69 voluntary participants (control 
group) presumably free of PAD (53% female, 46.5 ± 15.2 
[22–75] years, 4 diabetics). Table  1 shows demographic 
data of intervention and control group. Consistency of dif-
ferent groups is mandatory to exclude confounding. How-
ever, the aim of our study was to analyze the effectiveness 
and discriminatory power of sABI and aABI in a healthy 
and diseased population, separately. The diagnostic accu-
racy study was conducted in conformance with the Dec-
laration of Helsinki, approved by the local ethics com-
mittee (Ethikkommission des Saarlandes, Germany) and 
registered with the German Registry for Clinical Studies 
(DRKS) Trial No. DRKS00005777. Each participant pro-
vided written informed consent. Demographic information 
was acquired after consent was obtained.
Exclusion criteria included at least one of the following: 
participation in another study, malignancy, cardiac pace-
maker, limb surgery, current or pregnancy <12 months, 
necrosis at any measurement location, axillary lymphad-
enectomy, convulsions, spasms, tremor of any kind.
Individuals in the intervention-group were characterized 
by symptomatic PAD with an impaired walking capacity 
<200 m. All these patients had been consecutively referred 
to our angiography department for transfemoral catheter 
Table 1  Demographic data of 
study population Characteristics Symptomatic PAD n = 41 PAD-free n = 69 p value
Age (years) 69.0 ± 11.4 [40–94] 46.5 ± 15.2 [22–75] <0.0001
Female sex 17.1% 56.5% <0.0001
 Postmenopausal 100% 46.2% 0.0112
BMI (kg/m2) 27.5 ± 5.2 [18.4–41.8] 25.6 ± 4.3 [18.3–38.6] ns (0.060)
Diabetes mellitus 48.8% 5.8% <0.0001
 With Metformin 50% 1.5% –
 With Insulin 50% 0% –
 Both 5% 0% –
Smoker (pack years) 43.9% (53 ± 27 [25–150]) 14.5% (16 ± 12 [1–35]) 0.0012
Ex-smoker (years) 41.5% (16 ± 16 [1–50]) 20.3% (14 ± 10 [1.5–30]) 0.0274
Coronary heart disease 34.2% 0% <0.0001
Hypertension 73.2% 17.4% <0.0001
Dyslipidemia 56.1% 20.3% 0.0002
Regular alcohol intake 9.8% 0% <0.0001
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angiography combined with endovascular interventions. 
ABI, AS, and FMD measurements were performed before 
and after angiography. Interventional procedures (n = 44) 
included iliac stenting (n = 10), femoro-popliteal (n = 25) 
balloon-angioplasty or stenting, or endovascular aortic 
repair EVAR (n = 9). Three patients underwent combined 
procedures.
The control group encompassed PAD-free participants 
with a non-compromised, normal walking capacity. All 
these participants underwent only non-invasive ABI, AS, 
and FMD measurements.
In both groups, all measurements were performed in the 
morning by the same experienced investigator in a tem-
perature-controlled room (24 ± 1 °C) with the subject in a 
supine position, and after having rested supine for 15 min 
prior to measurements.
Comparison of sensitivity between ABI measurement 
methods
ABI measurements
Appropriately sized sphygmomanometric cuffs were used 
for sABI and aABI measurements. The participants rested 
supine for 15  min before pressure measurements were 
obtained.
Measurements for sABI were performed with a commer-
cially available unidirectional Doppler device (handydop, 
ELCAT, Wolfratshausen, Germany). A brachial pneumatic 
cuff was applied to the left upper arm, inflated to supra-
systolic pressure and deflated slowly until a Doppler-flow 
signal was detected. Determination of ankle pressure was 
determined similarly at both ankles with flow detection 
over the dorsal pedal and posterior tibial arteries. ABI was 
calculated as the higher of the two pedal pressures divided 
by the arm pressure. Measurements were taken in triplicate.
Measurements for aABI were also performed in tripli-
cate, immediately following the sABI measurements, using 
the VascAssist device (VA) (iSYMED GmbH, Butzbach, 
Germany). Four pneumatic cuffs were applied to both arms 
and distal lower legs. aABI was calculated for each extrem-
ity as the relevant ankle pressure divided by the higher of 
the two arm pressures.
Investigation of arterial stiffness index in comparison 
to FMD and ABI
FMD measurements
The FMD measurements were performed with patients 
in the supine position. Patients were instructed to avoid 
caffeine-, nicotine- and alcohol-containing products for 
at least 12 h before measurements. A blood pressure cuff 
was placed around the upper arm distal to the brachial 
artery segment that was explored. Ultrasound images 
were acquired using a commercially available ultra-
sound system with an 18  MHz high-resolution linear-
array transducer (Acuson S2000, Siemens Healthcare, 
Erlangen, Germany). The cuff was continuously inflated 
50 mmHg above the patient’s systolic blood pressure for 
5  min. Brachial artery diameter and flow velocity were 
recorded using 2D echography prior to cuff inflation, at 
deflation and after deflation at 1 min intervals for 5 min. 
The probe was angulated at 90° for optimal morphologic 
B-mode imaging and <60° for optimal velocity acquisi-
tion. Diameter measurements were made with electronic 
calipers at the end of ventricular diastole (Fig. 1).
Measurement of arterial stiffness index (AS)
For AS derivation, oscillometric blood pressure record-
ings were taken at the brachial and radial arteries of each 
arm in triplicate, subsequent to the FMD measurements. 
Pulse pressure curves were acquired at 1 kHz frequency. 
Proprietary PWA analysis algorithms were applied offline 
with the VascViewer software for Windows (iSYMED 
GmbH, Butzbach, Germany).
Statistical analyses
Analyses were performed offline, using STATA 11 soft-
ware (StataCorp, Texas, USA) by an investigator blinded 
to test conditions and patient identity. Demographic vari-
ables are presented as mean ± standard deviation and 
computed measures as mean ± standard deviation; cat-
egorical variables (i.e., diabetes status or sex) are pre-
sented as absolute frequencies and percentages.
Fig. 1  Ultrasound in M-mode (Acuson S2000 @18  MHz 18L6 40 
frames/s, Siemens Medical, Erlangen, Germany) illustrates cross-
sectional imaging of the brachial artery. The vessel diameter is 
determined according to the orthogonal distance between the intima 
reflexion zone (double arrow = 4.9 mm; longitudinal scale 25 mm)
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A power analysis was conducted before recruitment to 
determine the appropriate number of study subjects. With 
significance set at P ≤ = 0.05, and assuming a correla-
tion coefficient at r ≥ 0.3, 110 subjects provide a power 
of ≥0.89. Discrepancy of subject number in control and 
intervention group is based on the level of significance.
Correlation between measures was determined by linear 
regression. Agreement between aABI and sABI measure-
ments was investigated using the Bland–Altman method 
[20].
Pearson’s correlations were calculated between each 
ABI measurement mode, and to evaluate correlations 
between FMD and AS measurements. Paired samples’ 
t tests were conducted to analyze pre-intervention vs. 
post-intervention differences in AS. Shapiro–Wilk tests 
were performed to determine normality of differences 
between both measures. Since sABI was derived using 
left arm blood pressure values only, aABI was recalcu-
lated (using left brachial pressure values only) accord-
ingly for statistical analyses. To avoid the effects of inter-
relatedness of measures, within-subject ABI values were 
entered as independent observations for each leg.
Selection of ABI measurements for statistical analyses: 
The VascAssist software (VascViewer) alerts the investi-
gator to potential invalidity of individual pressure record-
ings based on a plausibility assessment of the detection 
of (a) end-diastolic nadir, (b) systolic peak pressure and 
(c) pulsatility of the ankle pressure curves.
Fig. 2  a A scatter plot illus-
trates a high correlation of 
R = 0.81 between standard Dop-
pler ABI and automated oscil-
lometric ABI measurements. 
Linear regression analysis 
reveals a probability P < .001. 
b Bland–Altman plot reveals 
high level of agreement between 
average and difference of the 
means of standard Doppler ABI 
and automated oscillometric 
ABI measurements
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Results
Overall, 278 ABI measurements were obtained in 110 par-
ticipants. Twenty-eight measurements were excluded: In 
nine instances, ABI acquisition was impossible for aABI 
and possible for sABI. In 11 instances, ABI acquisition was 
possible for aABI and not possible for sABI. Furthermore, 
in eight instances, ABI acquisition was neither possible for 
aABI nor for sABI. The reason for technical failures of ABI 
determination is speculative. Severe (media-)sclerosis and 
vessel occlusion should be the most probable assumption.
Comparison of sensitivity between ABI measurement 
methods
The number of patients misclassified as healthy was 11 
(26.8%) vs. 8 (19.5%) for aABI vs. sABI, respectively, 
which constitutes a non-significant difference at z = 1.18 
(P = .24). None of the healthy controls (n = 69) was mis-
classified by aABI vs. 3 misclassifications (4.3%) by sABI, 
which constitutes a non-significant difference at z = 1.69 
(P = .09). Expressed as sensitivity, specificity, positive 
predictive power and negative predictive power, the aABI 
method scored at 73, 100, 100, and 86%, respectively, 
whereas the sABI method had corresponding values of 80, 
96, 92, and 89%, respectively.
Level of agreement between sABI and aABI
Figure 2a shows the correlation between the two ABI meas-
urement modes. At r = 0.81 the agreement between sABI 
and aABI was highly significant (P < .001).
Before application of Bland–Altman analysis the dis-
tribution of the differences between the methods was 
inspected regarding normality. The differences were 
found to be normally distributed. Bland–Altman analysis 
Fig. 3  a A scatter plot illus-
trates a high correlation of 
R = 0.81 between standard Dop-
pler ABI and automated oscil-
lometric ABI measurements in 
the diabetic patients subgroup. 
Linear regression analysis 
reveals a probability p < .001. 
b Bland–Altman plot reveals a 
high level of agreement between 
average and difference of the 
means of standard Doppler ABI 
and automated oscillometric 
ABI measurements in the dia-
betic patients subgroup
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performed on all 250 measurements indicates a mean dif-
ference of 0.04, and 95% limits of agreement between the 
two methods ranging from −0.25 to 0.33 (Fig. 2b).
Additional investigations for patient subgroups
Since the prevalence of type 2 diabetes mellitus in the 
patient group provided for diabetes status-specific group-
ing of patients (a fact unforeseeable at the study’s planning 
stage) we became interested in a subgroup specific com-
parison of the two ABI measurement methods as described 
above.
When measurements were separated into diabetic and 
non-diabetic subgroups (20 subjects in symptomatic PAD 
group; 4 subjects in asymptomatic control group) in the 
respective values for bias and limits of agreements were 
0.09 and −0.22 to 0.4 for diabetics, and 0.022 and −0.25 
to 0.295 for non-diabetics, respectively (Figs. 3b, 4b). Pear-
son correlations between the two methods were r = 0.81 
(P < .001) and r = 0.77 (P < .001) for diabetics and non-
diabetics, respectively (Figs. 3a, 4a). Figure 5 illustrates the 
results of a subgroup of patients with symptomatic PAD 
(pain-free walking distance <200 m), who were scheduled 
for endovascular treatment. Pearson correlation coefficient 
between the two methods was r = 0.78 (P < .001), which 
highlights the power of automated oscillometric measure-
ment even in patients with clinically relevant PAD and, 
therefore, only low ABI.
Fig. 4  a A scatter plot illus-
trates a high correlation of 
R = 0.77 between standard Dop-
pler ABI and automated oscillo-
metric ABI measurements in the 
non-diabetic patients subgroup. 
Linear regression analysis 
reveals a probability P < .001. 
b Bland–Altman plot reveals a 
high level of agreement between 
average and difference of the 
means of standard Doppler ABI 
and automated oscillometric 
ABI measurements in the non-
diabetic patients subgroup
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Investigation of arterial stiffness index in comparison 
to flow-mediated dilatation (FMD)
Pre-intervention FMD and AS showed a borderline signifi-
cant correlation, with R = 0.386, P = .043. No correlation 
was observed between post-interventional FMD and AS 
(R = −0.06. P = .76). FMD increased non-significantly by 
0.15% from pre- to post-intervention (t = 1.57, P = .063).
Change of arterial stiffness pre- to post-intervention
Conversely, the increase in AS from a pre-intervention 
mean of 504.2 to a post-intervention mean of 704.4 was 
highly significant (t = 3.82, P < .001), reflecting a mean 
increase by 51 ± 54.1%, with 82% of patients (23 of 28) 
witnessing an increase in AS.
Discussion
Assessment of ankle-brachial index (ABI) is recommended 
for PAD screening by the current guidelines of the Euro-
pean Society of Hypertension and Cardiology. ABI acqui-
sition is usually made by non-invasive measurement with 
a very high sensitivity and specificity and considered as 
the method of choice [21–23]. However, standard Doppler 
ABI measurement is time-consuming and requires spe-
cific skills resulting in a lower frequency of its acquisition 
in daily routine [4, 5]. Doppler measurements necessitate 
additional steps, e.g., pulse auscultation and supra-systolic 
compression combined with Doppler signal evaluation. 
Consistency analysis has already shown a very large variety 
for training of ABI acquisition and outcome measures [24]. 
Recent studies have evaluated automated oscillometric 
blood pressure monitors, which have the potential to reduce 
examination time. Davies et al. described automated meas-
urements being significantly faster than Doppler meas-
urements (7 min 55 s vs. 17 min 45 s; p < .01) [5]. Oscil-
lometric and Doppler methods agree in terms of the ABI 
associations and differences as well as the diagnosis of 
PAD [25]. Oscillometric ABI assessment appears to be 
feasible, faster and accurate in clinical practice [26], while 
investigator-related intra-observer and inter-observer bias 
and error are reduced [7]. Simultaneous arm-leg measure-
ments resulted in a smaller difference between the average 
oscillometric ABI value and the average Doppler ABI than 
did sequential measurements [4, 5]. Data suggest that auto-
mated ABI measurement by oscillometric blood pressure 
devices is a reliable and practical alternative to the conven-
tional Doppler measurements for the detection of PAD. In 
case of erroneous or lack of oscillometric measurement the 
probability for PAD is very high [5]. A large meta-analysis 
revealed that oscillometric ABI determination is character-
ized by slightly higher ABI values. A possible explanation 
is a systematic error assessing Doppler ABI likely due to 
observer error caused by the delay between Doppler signal 
auscultation, viewing and recording the sphygmomanom-
eter for arm and ankle. Additionally, the (more sensitive) 
modified ABI (which means using the lower instead of the 
higher ankle pressure) is not possible because the oscillo-
metric method acquires the posterior and anterior (or dorsal 
pedal) tibial artery simultaneously [4]. The simultaneous 
measurements result in a significantly smaller ABI differ-
ence compared to sequential (Doppler ABI) assessment. 
Moreover, a clear advantage of simultaneous oscillomet-
ric assessment is prevention of random blood pressure 
variation [4, 5]. Since ABI measurements are acquired to 
rule out or suspect the presence of PAD—the latter case 
Fig. 5  A scatter plot illustrates 
a high correlation of R = 0.78 
between standard Doppler ABI 
and automated oscillometric 
ABI measurements in the 
subgroup of patients with symp-
tomatic PAD before endovascu-
lar treatment. Linear regression 
analysis reveals a probability 
P < .001
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necessitating follow-up investigations or invasive treatment 
procedures about improved and maintained vessel integ-
rity—correct assessment of PAD is the benchmark criterion 
to determine compatibility of ABI measurement methods. 
Therefore, the aim is to detect PAD at an early stage. Espe-
cially, in a population as it typically presents to a vascular 
health care provider, high discriminatory power in terms 
of secondary prevention is essential. Hence, the patients’ 
group included a majority of patients with diabetes melli-
tus. The control group consisted of PAD-free participants 
with a non-compromised, normal walking capacity. Incom-
pressibility of vessels secondary to atherosclerotic calcifi-
cation poses a challenge for performing ABI, as evidenced 
in the dramatically decreased sensitivity of ABI in diabetic 
patients. Which is why the additional information of PWV 
provided by an oscillometric device, together with the lat-
ter system’s recording of pulse pressure curves, contrib-
utes valuable information about the status of the vessels. 
Proper application of Bland–Altman analysis for evalua-
tion of two different methods typically requires an a priori 
definition of the acceptable limits of agreement to support 
or reject interchangeability of measurement methods [20]. 
The results of our study reveal absence of significant dif-
ference in classification between the two tested methods. 
There is only a small bias and acceptable limits of agree-
ment suggest the VascAssist device as a suitable substitute 
for Doppler-based measurement of ABI. Doppler-based 
ABI measurement is considered as the standard of choice. 
However, sequential measurement of blood pressure is used 
in the upper arms, the dorsal pedal and tibial arteries. Nor-
mal blood pressure fluctuations inevitably affect the results 
of the sABI calculation, which is determined as the ratio 
of pressures measured sequentially rather than simultane-
ously. Conversely, this inherent methodological flaw is not 
present, when using aABI as determined by VascAssist, 
because it provides simultaneous pressure recordings of 
arms and legs.
Increased AS is identified as an independent factor for 
cardiovascular mortality. It is typically associated with 
age, hypertension, diabetes, end-stage renal disease and 
peripheral arterial disease [27]. Central and peripheral 
Fig. 6  Illustrations of the automated oscillometric ABI measure-
ment: a Automated oscillometric acquisition of brachial (red) and 
ankle (blue) pulse pressure curves in a healthy individual are char-
acterized by clearly demarcated and identifiable curves with distinct 
systolic peaks. b Pulse pressure curve assessment in a patient suf-
fering symptomatic PAD with reduced pain-free walking distance 
<75 m is characterized by chaotic deviations from the normal rhyth-
mic pulsatility. c Data acquired by the VascAssist device processed 
by the VascViewer software averages ensembles of 15 heart cycles 
into one pressure tracing for analysis. The example shows a typical 
pressure wave in a healthy subject. d Corresponding to (b), data aver-
aging over several heart cycles into one pressure tracing in patients 
with PAD results in disordered curve shapes
▸
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arterial PWV are specific indicators and considered as the 
method of choice for the assessment of AS and the sever-
ity of peripheral vascular disease [28, 29]. ABI measure-
ments narrow the diagnostic focus to the systolic peaks of 
the pulse pressure curves, thereby neglecting the wealth of 
information contained in the latter. As a consequence, PWA 
is considered as a standard test for peripheral arterial dis-
ease in clinical practice, as it is the case for ABI. Central 
and peripheral PWV are related to ankle-brachial pressure 
index [30, 31]. Depending on the number and/or severity 
of stenoses, the downstream pressure curves may change 
from rhythmic pulsatility to chaotic tracings. As it is evi-
dent in Fig. 6a the systolic peaks of oscillometric brachial 
(red tracing) and ankle pressure (blue tracing) curves are 
clearly demarcated and identifiable in a healthy individual. 
Conversely, the ankle tracings of a patient with severe PAD 
resulting in an impaired walking capacity <30 m (Fig. 6b) 
show chaotic deviations from the normal rhythmic pulsatil-
ity. The device used in this study averages 15 heart cycles 
into one pressure tracing for analysis (healthy subject in 
Fig. 6c, claudicant in Fig. 6d). It could be argued that this 
method of ABI measurement provides more reliable and 
repeatable results than standard manual measurements, 
which derive ABI at a single time point at which measured 
systolic pressure may or may not coincide with the time-
averaged result of aABI measurement. Given a chaotic 
pressure curve, the degree of the two measurement meth-
ods is clearly left to chance. While the reliability of the 
ABI measurement can be verified by visual inspection of 
the pulse pressure tracing in the VascAssist, no such quality 
control is possible with standard ultrasound measurement.
Although a pathologic PWV has been described as pre-
ceding or accompanying cardiovascular diseases, evidence 
for such relationship in PAD is only less well documented 
[32, 33]. The present study provides strong data to support 
that clinically symptomatic PAD—diagnosed by invasive 
catheter angiography—is associated with a reduced PWV 
that increases after endovascular intervention. These data 
are in contrast to some other studies reporting on PWA 
in patients with PAD. But, in these studies definition and 
assessment of PAD with inclusion of arm and leg together 
with aortic large artery measurements on PWV was less 
well defined; i.e., ABI, the presence of claudication, or 
clinical evidence of arterial insufficiency was not required 
for the diagnosis of PAD [34, 35]. In contrast, our study is 
the first comparing functional vascular parameters includ-
ing ABI, FMD, and AS with inclusion of the arms and 
legs together with aortic PWV assessment in PAD patients 
suffering from a more severe stage of atherosclerosis than 
those previously reported. Moreover, the present study was 
conducted on symptomatic PAD patient before and after an 
endovascular intervention. There was only a weak correla-
tion between FMD and AS at baseline. This was probably 
just a chance finding since no correlation was observed fol-
lowing successful interventions. However, the strong and 
significant post-interventional increase of AS suggests that 
the improvement in arterial function, which is the objective 
of interventions in PAD patients, is obviously reflected in 
a change of AS. This finding warrants further investiga-
tions into the potential role of AS as an indicator of arterial 
health. Given its operator skill-independent mode of acqui-
sition, AS may be an attractive robust alternative to error-
prone FMD as a screening tool for arterial health. In addi-
tion it may serve as a control for successful PAD therapy by 
interventional means.
The limitations of the study consist of practical con-
straints on participant selection, which did not allow us to 
draw a random sample of the population in general or of 
the medical center’s patient population. Hence, the analysis 
of sensitivity, specificity, positive and negative predictive 
power may not apply to settings with substantially different 
proportions of diseased vs. healthy subjects. The conducted 
power analysis revealed 110 study subjects to be appropri-
ate for adequate statistical hypothesis testing. The number 
of recruited subjects per group is limited (41 patients with 
symptomatic PAD and 69 voluntary healthy participants in 
control group free of PAD), and consequently the number 
of diabetics for sub-analyses.
Conclusion
aABI measurement using the VascAssist device is 
interchangeable with manual ultrasound-based sABI 
measurement.
Arterial stiffness, as a result of total peripheral resistance 
and arterial compliance determined by PWV acquisition is 
a promising indicator of arterial health status and function, 
warranting further investigations for early detection of PAD 
in terms of secondary prevention.
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